Medical castration is a drug-based treatment that suppresses the body’s production of sex hormones, primarily testosterone or estrogen, to levels so low they’re functionally equivalent to what you’d see after surgical removal of the testes or ovaries. The clinical target is a testosterone level below 50 ng/dL, down from a typical male range of 300 to 1,000 ng/dL. Unlike surgical castration, medical castration is generally reversible once the medication is stopped, though full hormone recovery can take months to years.
How It Works
Your body produces sex hormones through a signaling chain that starts in the brain. A region called the hypothalamus releases a hormone (GnRH) in small, rhythmic pulses that tells the pituitary gland to release two messenger hormones: LH and FSH. These messengers then travel to the testes or ovaries and trigger testosterone or estrogen production. Medical castration interrupts this chain at the brain level using one of two drug classes.
The first class, called GnRH agonists, floods the pituitary with a constant signal instead of the natural pulsing rhythm. At first, this overstimulation causes a temporary spike in testosterone that can last one to two weeks. But the constant flooding eventually overwhelms the receptors, causing them to shut down. Once that happens, LH and FSH drop, and testosterone falls to castrate levels. This initial spike is called a “flare” and sometimes requires a short course of additional medication to block its effects.
The second class, GnRH antagonists, works faster and more directly. These drugs block the pituitary receptors outright, immediately preventing the release of LH and FSH. There’s no initial testosterone spike, which makes them preferable when a rapid drop in hormone levels is important. Patients on GnRH antagonists typically reach castrate testosterone levels within days rather than weeks.
What It’s Used For
The most common reason for medical castration is prostate cancer. Prostate tumors are frequently fueled by testosterone. Starving them of that fuel slows or stops their growth, particularly in advanced or metastatic disease. Medical castration is a cornerstone of treatment for these hormone-sensitive cancers and is often used alongside radiation, surgery, or newer targeted therapies.
Hormone-sensitive breast cancer in women can also be treated with forms of chemical castration that suppress estrogen. The goal is the same: cut off the hormone supply that feeds tumor growth. Male breast cancer, though rare, is sometimes treated this way as well.
Outside of cancer, similar hormone-suppression approaches are used in gender-affirming care for transgender women, though the medications and dosing protocols differ. In the U.S., spironolactone is the most commonly used testosterone blocker in feminizing hormone therapy, while other countries more frequently use cyproterone acetate. These aren’t typically called “medical castration” in that context, but the underlying principle of suppressing sex hormones is related.
Medical vs. Surgical Castration
Surgical castration (removal of the testes) achieves the same hormonal result but is permanent, happens in a single procedure, and requires no ongoing medication or follow-up injections. Medical castration requires regular treatment, whether that’s monthly injections, implants placed every few months, or daily oral pills, depending on the drug. Over time, the compounding cost of medication makes medical castration more expensive, while surgical castration has a higher upfront cost but nothing afterward.
Despite the cost and convenience advantages of surgery, medical castration is far more widely used. The reasons are partly psychological. Many patients prefer a reversible option, and the idea of surgery on the testes carries significant emotional weight. Socioeconomic factors play a role too: patients with reliable healthcare access and good insurance tend to choose the medical route. For patients with limited access to follow-up care, however, surgical castration’s permanence can actually be an advantage, since there’s no risk of missing doses or lapsing on treatment.
Side Effects of Hormone Suppression
Suppressing sex hormones affects far more than the reproductive system. Testosterone and estrogen play roles in bone strength, metabolism, mood, and cognition, so side effects can be wide-ranging.
Hot flashes are one of the most immediate and common effects. Bone density begins to decline within 6 to 12 months of starting treatment, and fracture rates increase within five years. This makes bone health monitoring an important part of long-term care. Hemoglobin levels also drop, though the decrease (around 10 to 15 g/L) is usually not severe enough to cause noticeable symptoms in most people.
Body composition shifts toward more fat and less muscle. Many patients gain weight, particularly around the midsection. Fatigue is common, and libido drops significantly or disappears entirely. Erectile dysfunction is nearly universal in men on these treatments.
The psychological effects deserve attention. A one-year follow-up study found that men on hormone suppression had measurably higher depression and anxiety scores during treatment. Verbal memory and some cognitive functions also declined while on the drugs, and these improved after treatment was discontinued. The mood changes were statistically significant, though for most patients they stayed in a mild range rather than reaching clinical severity.
How Long Effects Take and How Long They Last
GnRH antagonists suppress testosterone within days. GnRH agonists take two to four weeks to reach castrate levels because of the initial hormone flare. By three months on either drug class, testosterone levels typically sit well below the 50 ng/dL threshold, often dropping to single digits.
Recovery after stopping treatment is slower and less predictable than most patients expect. In a study of 208 men, 75% recovered to at least the castrate threshold (above 50 ng/dL) within a median of 11 months. But reaching a truly normal testosterone level of 350 ng/dL or higher was a different story: 81% of patients had not recovered to that level even after a median follow-up of over six years.
Duration of treatment matters significantly. Patients treated for less than two years generally recovered normal testosterone in about six months. Those treated for longer than two years needed a median of 22 months, and some never fully recovered. Age at the time of treatment also plays a role, with older patients recovering more slowly and less completely.
This incomplete recovery is one of the most important things to understand about medical castration. While it’s described as reversible, and it technically is in most cases, “reversible” doesn’t always mean “returns to exactly where it was.” For men treated over long periods, some degree of permanent hormonal change is common.
What the Treatment Looks Like Day to Day
The practical experience depends on which drug you’re prescribed. Some GnRH agonists come as injections given monthly, every three months, or every six months at a clinic. Others are small implants placed under the skin. GnRH antagonists have traditionally required monthly injections, though an oral option (relugolix) is now available and taken as a daily pill.
Between doses, there’s no daily routine related to the treatment itself, but managing side effects becomes part of everyday life. Weight-bearing exercise helps slow bone loss. Many patients are prescribed calcium and vitamin D supplements. The fatigue and body composition changes often require adjustments to diet and activity levels. For men experiencing significant mood changes, mental health support can make a meaningful difference in quality of life during treatment.